Indoco Remedies
283.40
-1.75(-0.61%)
Market Cap₹2,614.31 Cr
PE Ratio126.00
IndustryHealthcare
Company Performance:
1D-0.61%
1M+9.00%
6M-16.34%
1Y-12.88%
5Y+32.34%
View Company Insightsright
Latest news about Indoco Remedies
Indoco Remedies Relieved as GST Authority Drops ₹85 Million Demand 6 days ago
The GST Authority has discontinued legal proceedings against Indoco Remedies, a major pharmaceutical company, effectively nullifying a potential demand of ₹85.00 million (₹8.50 crore). This decision removes a significant financial liability from the company's books, potentially improving its financial outlook and market perception. The resolution allows Indoco Remedies to refocus on its core business operations without the burden of ongoing GST proceedings.
Indoco Remedies Secures FDA Approval for Allopurinol Tablets May 23, 2025
Indoco Remedies Reports Q4 Loss, Revenue Drop; Shares Slump 7% May 22, 2025
Indoco Remedies' AnaCipher Facility Completes FDA Inspection with One Form 483 Mar 11, 2025
Indoco Remedies' AnaCipher Facility Completes FDA Inspection with One Form 483 Observation Mar 10, 2025